Leadership
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
From Regulatory Affairs To R&D, Sanofi’s Mura Has Broad Strategic View
From a legal family in her native Brazil, Raquel Mura built on her passion for science to work in consumer health care, nutritionals and pharmaceuticals, rising to an R&D leadership position at Sanofi.
Elizabeth Jungman: Interpreter Of The FDA’s Policy Crystal Ball
The Center for Drug Evaluation and Research’s policy guru must think about the future, along with the present, in her position as director of the Office of Regulatory Policy.
Muvon Therapeutics: The Road To Expansion
Deana Mohr, Muvon Therapeutics’ co-founder and chief executive, and one of In Vivo’s 2022 Rising Leaders, aspires to push the organization to the next level by scaling up the company and developing its therapies into marketable products.
Execs On The Move: April 2022
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
The Importance Of Mentorship: Turning Scientists Into Leaders
Merck’s head of clinical immunology and 2022 Rising Leader Aileen Pangan is empowering researchers to become leaders through a highly tailored and honest approach to mentorship.
Bernasconi: Europe Needs A Better Strategic Rudder For Medtech Innovation Policy
Always ready to frame the needs of EU medtechs clearly and succinctly, MedTech Europe CEO Serge Bernasconi says that the local industry in the future could benefit from more strategic direction and support from a dedicated EU agency or similar tighter governance structure.
OMass Therapeutics: The 21st Century Vertex?
Hot on the heels of an oversubscribed series B round, OMass CEO and Rising Leader Ros Deegan spoke with In Vivo about her move from pharma to biotech, mass spectrometry and big dreams for the firm.
Execs On The Move: March 2022
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
From Supertankers To Speedboats: Executives Make The Leap From Big Pharma To Start-Ups
Vir’s George Scangos, Westlake Village BioPartners’ Sean Harper, Kronos Bio’s Norbert Bischofberger, Scorpion’s Axel Hoos and Eikon’s Roy Baynes discuss the experiences they bring and the challenges they have faced in the transition from large drug makers to small biotechs.
Leading By Example: A Starting Point To Address Disparities In Health Care
As the head of inclusive investments and partnerships lead for Publicis Health Media, Karima Sharif’s expertise in media and strategy has led to the development of rich relationships. She oversees partnerships with more than 600 firms, ranging from lifestyle groups – such as NBC – to endemic HCP partners, such as the New England Journal of Medicine and WebMD.
Improving Clinical Trials In Psychiatric Health Care
Kiri Granger, Monument Therapeutics’ chief scientific officer and executive director, and one of In Vivo’s 2022 Rising Leaders, hopes to take the company to the next level by rejecting the conventional one-size-fits-all approach to psychiatric clinical trials.
From People To Planet: The Endless Potential Of CRISPR Gene Editing
Caszyme CEO and 2022 Rising Leader Monika Paule is on a mission to expand the CRISPR toolbox of available proteins to enhance diagnostic tools, therapeutics and even agricultural practices.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.